The dysfunction of the IL-23/IL-17 pathway has been observed in various autoimmune disorders, including psoriasis, rheumatoid arthritis, inflammatory bowel disease (IBD), and spondylarthritis (SpA). This evidence concerns the gene IL17A and inflammatory bowel disease.